"This study was attractive because the drug was oral, and patients don't have to come into the center. They can take it from home," Dr. Wendland says. Read more.
The first two chronic lymphocytic leukemia (CLL) patients ever in the world to receive a new, potentially life-saving drug for B-cell cancers were part of a clinical trial run by Dr. Jeff Sharman at WVCI. Read more.
It's an exciting time in cancer research, especially concerning chronic lymphocytic lymphoma (CLL). Dr. Jeff Sharman, Willamette Valley Cancer Institute and Research Center's research director, specializes in CLL and presented studies at the American Society of Hematology conference in December. Read more.
While in Atlanta for the conference, he sat down for an interview with Dr. Andrew Schorr of Patient Power to talk about CLL research and how the direction of treatment is changing, from traditional chemotherapy to targeted therapies...
Amidst the hustle and bustle of the season, holidays can be difficult for cancer patients and their caregivers. It can also be a painful time for people who've lost loved ones. Read more.
For those going through cancer treatment, partaking in traditional holiday activities — shopping, entertaining, attending events, even wrapping presents — can be a challenge when energy is lacking. To-do lists and planning can also add unhealthy stress...
September is National Ovarian Cancer Awareness Month, a time to raise awareness about the ninth most common cancer among women.
To learn more about how to reduce your risk or catch it early, when it's most treatable, read our three-part series... Read more.